Yanhong Gu, Tianzhu Qiu, Lu Mingjie, Yuwen Dong. "Fruquintinib plus camrelizumab combined with paclitaxel liposome and nedaplatin as first-line treatment for advanced esophageal squamous cell carcinoma (ESCC): A single-arm, phase II clinical trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.4_suppl.445